News Author: Susan London Publish date: June 27, 2016
SAN FRANCISCO – Hospitalized patients who have a change in the medical residents responsible for their care are more likely to die, finds a retrospect...
News Author: Susan London Publish date: June 15, 2016
Key clinical point: Delaying initiation of renal replacement therapy in critically ill patients with kidney injury appears safe and beneficial.
Ma...
News Author: Susan London Publish date: June 14, 2016
Key clinical point: When added to standard of care, edaravone slows loss of function in patients with early-stage ALS.
Major finding: Compared wit...
News Author: Susan London Publish date: June 14, 2016
Key clinical point: In real-world care, dimethyl fumarate and fingolimod appear more effective than other disease-modifying therapies for MS.
Majo...
News Author: Susan London Publish date: June 13, 2016
Key clinical point: Atezolizumab is efficacious when used as first-line therapy in advanced urothelial cancer.
Major finding: The overall response...
News Author: Susan London Publish date: June 11, 2016
Extending adjuvant aromatase inhibitor (AI) therapy from 5 years to 10 years further reduces the risk of recurrence and new breast cancer in postmenop...
News Author: Susan London Publish date: June 9, 2016
Key clinical point: Daratumumab improves outcomes when added to the current standard of care in relapsed or refractory myeloma.
Major finding: Add...
News Author: Susan London Publish date: June 9, 2016
Key clinical point: Mechanically ventilated ICU patients have poorer outcomes if they are extubated during the night instead of during the day.
Ma...
Video Author: Susan London Publish date: June 6, 2016
Video Author: Susan London Publish date: June 6, 2016
Video Author: Susan London Publish date: June 5, 2016
News Author: Susan London Publish date: June 5, 2016
Key clinical point: The cell cycle inhibitor abemaciclib is active in refractory HR+, HER2– metastatic breast cancer.
Major finding: The ove...
Video Author: Susan London Publish date: June 4, 2016
News Author: Susan London Publish date: June 4, 2016
Key clinical point: Adding capecitabine to adjuvant gemcitabine nets a survival benefit in pancreatic cancer, without added serious toxicity.
Majo...
News Author: Susan London Publish date: May 25, 2016
Key clinical point: Overall, respondents were knowledgeable about inhalational devices used to treat COPD, but some gaps were evident.
Major findi...
